Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Magnetic resonance imaging-guided single-fraction preoperative radiotherapy for early-stage breast cancer (the RICE trial): feasibility study.
Qadir A, Singh N, Dean J, Brown K, Tacey M, Mann B, Kron T, Cahoon G, Lau E, Scott AM, Yeo B, Loh SW, Uribe S, Moe AAK, Ireland-Jenkins K, McAuley R, McDermont L, Ooi WM, Ng S, Chao M, Foroudi F. Qadir A, et al. Among authors: foroudi f. Pilot Feasibility Stud. 2024 Nov 7;10(1):133. doi: 10.1186/s40814-024-01557-6. Pilot Feasibility Stud. 2024. PMID: 39506820
Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial.
Huddart R, Hafeez S, Griffin C, Choudhury A, Foroudi F, Syndikus I, Hindson B, Webster A, McNair H, Birtle A, Varughese M, Henry A, McLaren DB, Parikh O, Nikapota A, Tang C, Patel E, Miles E, Warren-Oseni K, Kron T, Hill C, Philipps L, Vassallo-Bonner C, Cheung KC, Gribble H, Lewis R, Hall E. Huddart R, et al. Among authors: foroudi f. Eur Urol. 2024 Sep 24:S0302-2838(24)02596-X. doi: 10.1016/j.eururo.2024.09.006. Online ahead of print. Eur Urol. 2024. PMID: 39379236 Free article.
Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age.
Armstrong A, Ho H, Mark Tacey M, Bolton D, Chan Y, Tan A, Cham CW, Pham T, McMillan K, Koufogiannis G, Dip G, Manohar P, Guerrieri M, Ng M, Joon DL, Foroudi F, Tan MY, Chao M. Armstrong A, et al. Among authors: foroudi f. J Contemp Brachytherapy. 2024 Feb;16(1):6-11. doi: 10.5114/jcb.2024.135630. Epub 2024 Feb 23. J Contemp Brachytherapy. 2024. PMID: 38584883 Free PMC article.
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
Siva S, Bressel M, Sidhom M, Sridharan S, Vanneste BGL, Davey R, Montgomery R, Ruben J, Foroudi F, Higgs B, Lin C, Raman A, Hardcastle N, Hofman MS, De Abreu Lourenco R, Shaw M, Mancuso P, Moon D, Wong LM, Lawrentschuk N, Wood S, Brook NR, Kron T, Martin J, Pryor D; FASTRACK II Investigator Group. Siva S, et al. Among authors: foroudi f. Lancet Oncol. 2024 Mar;25(3):308-316. doi: 10.1016/S1470-2045(24)00020-2. Lancet Oncol. 2024. PMID: 38423047 Clinical Trial.
196 results